Bird C H, Christensen M E, Mangan M S J, Prakash M D, Sedelies K A, Smyth M J, Harper I, Waterhouse N J, Bird P I
Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Melbourne, VIC, Australia.
Apoptosis and Cytotoxicity Laboratory, Mater Medical Research Institute, Brisbane, QLD, Australia.
Cell Death Differ. 2014 Jun;21(6):876-87. doi: 10.1038/cdd.2014.7. Epub 2014 Jan 31.
Cytotoxic lymphocytes (CLs) contain lysosome-related organelles (LROs) that perform the normal degradative functions of the lysosome, in addition to storage and release of powerful cytotoxins employed to kill virally infected or abnormal cells. Among these cytotoxins is granzyme B (GrB), a protease that has also been implicated in activation (restimulation)-induced cell death of natural killer (NK) and T cells, but the underlying mechanism and its regulation are unclear. Here we show that restimulation of previously activated human or mouse lymphocytes induces lysosomal membrane permeabilisation (LMP), followed by GrB release from LROs into the CL cytosol. The model lysosomal stressors sphingosine and Leu-Leu-methyl-ester, and CLs from gene-targeted mice were used to show that LMP releases GrB in both a time- and concentration-dependent manner, and that the liberated GrB is responsible for cell death. The endogenous GrB inhibitor Serpinb9 (Sb9) protects CLs against LMP-induced death but is decreasingly effective as the extent of LMP increases. We also used these model stressors to show that GrB is the major effector of LMP-mediated death in T cells, but that in NK cells additional effectors are released, making GrB redundant. We found that limited LMP and GrB release occurs constitutively in proliferating lymphocytes and in NK cells engaged with targets in vitro. In Ectromelia virus-infected lymph nodes, working NK cells lacking Sb9 are more susceptible to GrB-mediated death. Taken together, these data show that a basal level of LMP occurs in proliferating and activated lymphocytes, and is increased on restimulation. LMP releases GrB from LROs into the lymphocyte cytoplasm and its ensuing interaction with Sb9 dictates whether or not the cell survives. The GrB-Sb9 nexus may therefore represent an additional mechanism of limiting lymphocyte lifespan and populations.
细胞毒性淋巴细胞(CLs)含有溶酶体相关细胞器(LROs),这些细胞器除了储存和释放用于杀死病毒感染细胞或异常细胞的强效细胞毒素外,还执行溶酶体的正常降解功能。这些细胞毒素中包括颗粒酶B(GrB),一种蛋白酶,它也与自然杀伤(NK)细胞和T细胞的激活(再刺激)诱导的细胞死亡有关,但其潜在机制及其调控尚不清楚。在这里,我们表明,对先前激活的人或小鼠淋巴细胞进行再刺激会诱导溶酶体膜通透性增加(LMP),随后GrB从LROs释放到CL细胞质中。使用模型溶酶体应激物鞘氨醇和亮氨酸-亮氨酸-甲酯,以及来自基因靶向小鼠的CLs,以表明LMP以时间和浓度依赖性方式释放GrB,并且释放的GrB负责细胞死亡。内源性GrB抑制剂丝氨酸蛋白酶抑制剂b9(Sb9)可保护CLs免受LMP诱导的死亡,但随着LMP程度的增加,其效果逐渐降低。我们还使用这些模型应激物表明,GrB是T细胞中LMP介导的死亡的主要效应物,但在NK细胞中会释放其他效应物,使GrB变得多余。我们发现,在增殖淋巴细胞和体外与靶标结合的NK细胞中,有限的LMP和GrB释放是组成性发生的。在感染埃可病毒的淋巴结中,缺乏Sb9的活性NK细胞更容易受到GrB介导的死亡影响。综上所述,这些数据表明,在增殖和激活的淋巴细胞中会发生基础水平的LMP,再刺激时会增加。LMP将GrB从LROs释放到淋巴细胞细胞质中,其随后与Sb9的相互作用决定了细胞是否存活。因此,GrB-Sb9关系可能代表了限制淋巴细胞寿命和数量的另一种机制。